Go back to blogKeeogo is an advanced exoskeleton system developed by B-Temia Inc., aimed at assisting patients with physical disabilities who experience difficulty with walking due to conditions such as stroke. Unlike traditional exoskeletons and mobility aids that can be cumbersome or limiting, Keeogo provides users with a dynamic support system that adapts to their natural movements and provides assist-as-needed support on the go.
The Science Behind the Keeogo Exoskeleton
At the heart of Keeogo's functionality lies sophisticated sensor technology and artificial intelligence (AI) algorithms. These components work seamlessly together to interpret the user's movement intentions and activity initiations in real-time. By detecting subtle changes in posture and motion through sensors embedded within the device, Keeogo provides activity appropriate assistance by activating motors at the knees. This intelligent response helps users to maintain balance and control while reducing physical exertion during walking activities.
The design philosophy behind Keeogo emphasizes user autonomy and comfort. The exoskeleton is lightweight like an orthotic, yet sturdy enough to offer necessary support without restricting freedom of movement. Its ergonomic structure ensures that it complements rather than hinders natural biomechanics. With Keeogo users can do advanced exercises such as ascending and descending stairs, squats, lunges, and even jogging.
A New Versatile and Affordable Option for the Clinic
Keeogo offers a versatile solution for a wide range of clinical settings including inpatient hospitals, outpatient clinics and wellness centers. Its adaptability makes it suitable for various stages of recovery, offering significant benefits in clinical settings. Keeogo does not have a weight limit and offers a customizable fit for a wide range of patients and ability levels, similar to an orthosis.
Clinicians can tailor Keeogo's assistance levels according to individual patient needs, promoting gradual improvement in strength and endurance. By facilitating exercises like walking on flat surfaces or navigating stairs within a controlled environment, Keeogo helps build confidence while ensuring patient safety through its responsive technology.
Keeogo presents a cost-effective option for clinics seeking a new lightweight and innovative solution for high intensity gait training that prioritizes comfort and free movement.
Historical Roots: From ONYX to Keeogo
Keeogo's development is rooted in advanced military technology. Initially pioneered by B-Temia in partnership with Lockheed Martin through their ONYX exoskeleton project, ONYX was designed to augment soldiers' capabilities by reducing fatigue and enhancing performance during demanding tasks such as carrying heavy loads and equipment.
B-Temia recognized the potential applications of this cutting-edge technology beyond defense sectors and adapted it for civilian use. By leveraging insights gained from ONYX's development process, B-Temia successfully translated military-grade innovations into practical solutions for advanced mobility training.
A Significant Advancement in the Field
Keeogo represents a significant advancement in the field of exoskeleton technology. Keeogo’s sophisticated AI, and combination of robotic and sensor-based technologies allow it to provide a unique adaptable experience with unparalleled freedom of movement. Keeogo's design prioritizes autonomy and comfort, allowing users to engage in a wide range of activities with ease. It's a customizable solution that caters to diverse patient needs without compromising safety or effectiveness.
If you would like to sign-up for blog notifications fill out the form below. To request more information or learn more about Keeogo, email us at info.us@dih.com.
**DIH is an authorized distributor of Keeogo in the United States. Keeogo is intended to assist with ambulatory function post stroke in rehabilitation settings under the supervision of a trained healthcare professional. Images or testimonials in this article may not reflect the cleared indication for use in the United States. Please contact DIH for more information**
X
